1. Acute Myocardial Infarction: Risk Stratification in the Thrombolytic Era 
Guy S. Reeder, M.D., Raymond J. Gibbons, M.D. 
Mayo Clinic Proceedings 
Volume 70, Issue 1, Pages (February 1995)
DOI: /
Copyright © 1995 Mayo Foundation for Medical Education and Research Terms and Conditions

2. Fig. 1
Severity of disease assessed by angiography. Number of diseased vessels in patients in prethrombolytic studies and in Thrombolysis in Myocardial Infarction (TIM1) trial. cath = catheterization; VD = vessel disease.
(From Rogers and assoelates.46 By permission of the American College of Cardiology.)
Mayo Clinic Proceedings  , 87-94DOI: ( / )
Copyright © 1995 Mayo Foundation for Medical Education and Research Terms and Conditions

3. Fig. 2
Patient selection effects in risk stratification studies in thrombolytic era. * = high-risk patients excluded before noninvasive testing—selection effects that render noninvasive testing less useful for predicting death or myocardial infarction (MI) in current era of thrombolytic therapy. PTCA = percutaneous transluminal coronary angioplasty.
Mayo Clinic Proceedings  , 87-94DOI: ( / )
Copyright © 1995 Mayo Foundation for Medical Education and Research Terms and Conditions

4. Fig. 3
Mortality at 2 weeks relative to number of “not low-risk” factors (see Table 4).
Mayo Clinic Proceedings  , 87-94DOI: ( / )
Copyright © 1995 Mayo Foundation for Medical Education and Research Terms and Conditions